Exposure to colibactin, a toxin produced by some E coli bacteria, is a leading suspected factor in the rise of bowel cancer among people under 50, scientists told MPs. Researchers say more work is needed to establish whether the toxin drives early onset colorectal cancer.
Cases of early onset bowel cancer have doubled in many countries over the past two decades. Rising obesity and declining physical activity are contributors, but researchers believe other factors are also involved. Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the Commons science and technology committee that known risk factors such as obesity, smoking and alcohol explain only about half of the cases doctors diagnose.
Smith-Byrne said he did not find it “plausible” that existing risk factors could entirely explain the rise. Last year, scientists identified colibactin, produced by some variants of E coli in the gut, as a potential driver. Hallmark mutations caused by the toxin were three times more common in tumours from people under 40 than in those from people over 70.
“That’s probably the leading explanation at the moment,” Smith-Byrne told MPs. He said mutations caused by exposure during a sensitive period early in life could give the colon or rectum “a head start on its journey towards being cancerous or developing these tumours”. Smith-Byrne is himself a survivor of early onset rectal cancer.
Prof Mike Stratton at the Sanger Institute, who was not at the hearing, has said colibactin causes mutations in some children but not others, with evidence of mutations appearing as early as infancy. His work showed that by age 10, affected children can have a similar “mutational burden” to a 50-year-old.
Some researchers suspect that particular variants of E coli, which normally live harmlessly in the gut, have evolved in recent decades to produce colibactin. Prof Elio Riboli, a cancer epidemiologist at Imperial College London, told the committee: “This colibactin is essentially found in people born after 1960. Something has happened in the E coli bacteria … There must have been a mutation, and there is a new bacteria.”
Bowel cancer is the world’s third most common cancer, accounting for about one in 10 cases. It remains far more common in people over 50, but global figures suggest diagnoses are rising steeply among younger people.
Prof Helen Coleman, a cancer epidemiologist at Queen’s University Belfast, called colibactin “the first new clue that we’ve had in quite some time”, while stressing that its possible role in bowel cancer is still being investigated. She told MPs: “Even though we’re talking about adults that are being diagnosed with cancer between 18 and 49, it’s quite likely to be very early life exposures,” adding that exposure could occur in early childhood or possibly the prenatal period, making it difficult to study.
Riboli said researchers need to identify unknown cancer drivers, while people should also reduce risks that are already understood. He said that in the UK and US, drinking and smoking are falling, but obesity is rising and physical activity is declining. “The quick win could come from applying what we know,” he said. “We could prevent about 60% of the cancers occurring now, but we are not applying in society what we know.”
